What is the revenue and EPS growth rate for Sila Realty year over year?

What were the key takeaways from Sila Realty’s earnings call?

What is the market's earnings forecast for Sila Realty next quarter?

What is Sila Realty's gross profit margin?

Did Sila Realty beat or miss consensus estimates last quarter?

What factors drove the changes in Sila Realty's revenue and profit?

What is Sila Realty's latest dividend and current dividend yield?

What guidance did Sila Realty's management provide for the next earnings period?

- **Acquisition Strength**: $150M in 2025 acquisitions, with 150-200bps higher returns on redevelopments. 
- **Credit Quality**: 40.6% investment-grade guarantors, EBITDARM coverage 5.9x. 
- **Liquidity & Growth**: $480M liquidity, $200M+ deployment capacity. 
- **Tenant Stability**: 90% lease renewal rate, 10-year WA lease term. 
- **Strategic Sales**: Alexandria sold for $14.5M with strong holdover rent collection.

**【CEO Summary Section】**
- **2025 Performance Overview**: Acquired 6 healthcare facilities totaling $150M, with an additional $43.1M post-year-end acquisition. Disposed of 4 properties, including the Saginaw facility sold for $14.5M. Achieved 90% lease renewal rate on expiring GLA, increasing weighted average lease term to 10 years. Tenant credit quality improved to 40.6% investment-grade guarantors.
- **Portfolio Optimization**: Completed $7M in redevelopment projects with 150-200bps higher returns than acquisitions. Stoughton Facility demolition reduced carrying costs to $35K/month. Alexandria Healthcare Facility sold for $14.5M after collecting $120K in holdover rent.
- **Tenant Upgrades**: Washington Regional Medical Center (investment-grade) took over Fayetteville facility. Cencora's acquisition of OneOncology enhances sponsorship for 7 properties.

**【CFO Financial Commentary】**
- **Financial Results**: Cash NOI of $169.9M (+0.8% YoY), FFO per share $2.16 (+3.6%), AFFO per share $2.18 (-5.8%). EBITDARM coverage improved to 5.9x (vs. 5.3x). 
- **Balance Sheet**: Net debt/EBITDAre at 3.9x, liquidity of $480M. Available capital deployment of $200M+ to reach leverage midpoint.

**【Q&A Highlights】**
- **Alexandria Sale**: Collected $120K in Q4 holdover rent. El Segundo redevelopment in free rent period but considered leased. 
- **Acquisition Pricing**: Caps range 6-7.5% for MOB/ASC, 7%+ for LTAC/surgical hospitals. 
- **Capital Allocation**: Cautious on stock repurchases due to liquidity concerns. $225M-$375M deployment capacity for 2026, focusing on high-return portfolio expansions.

Sila Realty Trust, Inc. (SILA) Q4 2025 Earnings Call Transcript

- **Acquisition Dominance**: $87M in strategic health care asset purchases drive growth
- **High-Yield Expansions**: $43.5M in capital deployments yielding 150-300bps over cap rates
- **Financial Resilience**: 4.9% cash NOI growth, 75.8% tenant EBITDARM coverage
- **Tenant Stability**: 90% lease renewals, stable credit watch list
- **Capital Flexibility**: $200M+ available for 2026 acquisitions, $476M liquidity

**【CEO Summary Section】**
- **Acquisition Activity**: Secured $87 million in health care assets, including the Southlake portfolio (medical outpatient building & ASC) and Reunion Nobis IRFs in Texas and Arizona. 
- **Capital Deployment**: 
  - $5 million for San Antonio IRF redevelopment (20-year lease)
  - $12.5 million Dover expansion (13k sq ft, 12 beds)
  - $16 million Overland Park expansion (2 floors, 17 beds)
- **Tenant Renewals**: 90% of 2025 expirations renewed, including 58k sq ft in Q3.
- **Strategic Moves**: 
  - Terminated CHS lease at Fayetteville, replacing with Washington Regional (17.5-year lease)
  - Alexandria tenant vacated 15.6k sq ft (0.3% ABR), paid full holdover rent through Oct.
  - Pipeline of $43 million in 2026 acquisitions

**【CFO Financial Commentary】**
- **Cash NOI**: $42.8M (4.9% YoY growth, 1.2% same-store)
- **AFFO**: $0.92 per share (down 0.8% YoY due to interest expense)
- **Balance Sheet**: 
  - $476M liquidity (3.9x net debt/EBITDA)
  - 71% AFFO payout ratio
  - $75M share repurchase program authorized
- **Tenant Credit**: 
  - 75.8% of tenants reporting EBITDARM
  - 6.19x coverage ratio (5.31x excluding outlier)

**【Q&A Highlights】**
- **CHS Termination**: $200k payment expected in Q4
- **Capital Deployment**: $200-220M available for 2026 acquisitions
- **Tenant Credit**: Watch list stable, 2025 rent collection strong
- **Share Buybacks**: Repurchase program and ATM program provide flexibility
- **Development Yields**: 150-300bps over acquisition cap rates

Sila Realty Trust, Inc. (SILA) Q3 2025 Earnings Call Transcript

- **Strong financial metrics**: 5.31x EBITDARM coverage, 99.2% lease rate, and $568M liquidity.
- **Active acquisition pipeline**: $70M+ under LOI with 6.5%-7.5% cap rates, and $75M year-to-date closings.
- **Share repurchase strategy**: $7.3M executed, with $75M Board authorization over 3 years.
- **Stoughton resolution**: $1.9M demolition cost, reducing carry costs 83% by end-2025.
- **Dividend sustainability**: 74% AFFO payout ratio supporting $0.40 quarterly dividend.

**【CEO Summary Section】**
- **Robust operating performance**: 5.31x EBITDARM coverage ratio, 9.5-year weighted average lease term, and 2.2% annual contractual rent growth.
- **Strategic acquisitions**: $75M year-to-date in high-quality healthcare assets, including Dover IRF and Southlake MOB portfolio. Over $70M in properties under exclusive LOI.
- **Share repurchases**: $7.3M executed at $24.09/share, with Board approval for $75M over 3 years (capped at $25M/year).
- **Stoughton asset resolution**: Demolition expected by end-2025, reducing monthly carry costs from ~$120K to ~$20-25K. Entitlement for land sale in 2026.
- **Portfolio strength**: 99.2% lease rate, 40% of tenancy with investment-grade affiliations, and $568M liquidity.

**【CFO Financial Commentary】**
- **Cash NOI**: $41.9M (1.7% Q/Q growth, 5% Y/Y growth) driven by acquisitions and same-store 1.5% growth.
- **AFFO**: $0.54/share (1.7% Q/Q growth), with 74% payout ratio supporting $0.40 quarterly dividend.
- **Balance sheet**: Net debt-to-EBITDA of 3.6x, $568.8M liquidity, and no near-term debt maturities.
- **Share repurchases**: $7.3M executed, accretive to NAV and earnings. Future repurchases contingent on share price dislocation.

**【Portfolio Activity & Q&A Highlights】**
- **Pipeline visibility**: $70M+ in accretive healthcare assets under LOI, with cap rates 6.5%-7.5% and long lease durations.
- **Leasing momentum**: 3 renewals (+ rent spreads), 2025 expirations (4.6% ABR) all expected to renew, and 2026 expirations (3.8% ABR) in active dialogue.
- **Mezzanine loans**: $60M in development funding for IRF and behavioral health facilities, with purchase options upon completion.
- **Stoughton demolition costs**: $1.9M total, treated as non-recurring expense. Entitlement process expected to take ~12 months.
- **Financing strategy**: Use revolver for near-term acquisitions, with potential private placement for longer-term debt if rates stabilize.


Sila Realty Trust, Inc. (SILA) Q2 2025 Earnings Call Transcript

- **Portfolio Strength**: 96% leased with 9.7-year WALE, 73.3% of ABR from tenants with >5.3x EBITDARM coverage.
- **Growth Drivers**: Baby boomer surge expected to boost outpatient spending by 31% by 2030, supporting 2.2% annual rent escalations.
- **Balance Sheet Health**: 3.5x net debt/EBITDAre, $598M liquidity, and 76.4% AFFO payout ratio.
- **Strategic Moves**: $59M Q1 acquisitions, exploring Stoughton multifamily development with 12-18 month timeline.
- **Cautious Growth**: Annual acquisition target of $150-250M but pace tempered by stock price below NAV.

**【CEO Opening Remarks】**
- Highlighted portfolio stability with 96% leased portfolio and weighted average remaining lease term of 9.7 years.
- Emphasized healthcare real estate as a 'safe haven' with non-discretionary demand driven by aging population (baby boomer surge expected to increase outpatient spending by 31% by 2030).
- Recent acquisitions: $59M in Knoxville (TN) and Dover (DE) inpatient rehab facilities, expanding into 2 new states.
- Discussed Stoughton asset strategy: exploring multifamily development with 12-18 month timeline, potential for higher returns than current write-down.

**【CFO Financial Summary】**
- Q1 2025 Cash NOI: $41.2M (+0.5% QoQ) driven by lease escalations and Knoxville acquisition, offset by Stoughton carrying costs.
- AFFO: $29.4M ($0.53/share) vs. $30.2M ($0.54/share) in Q4 2024, down 23.1% YoY due to higher interest costs from 2024 swap repricing.
- Balance sheet: $526.5M net debt (3.5x net debt/EBITDAre), $598M liquidity, and 76.4% AFFO payout ratio.
- 73.3% of ABR from tenants with EBITDARM coverage >5.3x, 26.7% from non-reporting tenants (50%+ with investment-grade affiliations).

**【CIO Portfolio Updates】**
- Acquired 2 new properties in Q1: Knoxville (TN) and Dover (DE) inpatient rehab facilities totaling $59M.
- Leasing activity: renewed/extended 122,000 sqft (102,000 sqft in Lubbock, TX), maintaining 2.2% annual rent escalations.
- Savannah (GA) property tenant bankruptcy resolved with full rent payments.
- Pipeline remains active but cautious due to macroeconomic uncertainty.

**【Q&A Highlights】**
1. **Stoughton Asset**: Exploring demolition and multifamily development with 12-18 month timeline, potential for higher returns than current $1.2M write-down.
2. **Mezz Loan Investments**: $171K credit loss reserve added for 2 mezz loans, fully funded by Q3 2025.
3. **Investment Pipeline**: Targeting $150-250M annual acquisitions at 6.5-7.5% cap rates, but pace cautious due to stock price below NAV.
4. **Debt Strategy**: Revolver cost at 5.57%, no immediate plans for fixed-rate debt due to higher market rates (200bps+ over 10-year).

Sila Realty Trust, Inc. (SILA) Q1 2025 Earnings Call Transcript

- **Record 2024 Growth**: $164M in acquisitions, including two mezzanine loans with mid-teens returns and purchase options.
- **Portfolio Resilience**: 99.9% net lease structure, 9.7-year WALE, <2% ABR below 1x EBITDARM.
- **Balance Sheet Strength**: $600M credit facility (70% oversubscribed), 3.3x net debt-to-EBITDAre.
- **2025 Outlook**: 7.5-15% portfolio expansion target. Focus on Sunbelt healthcare facilities with investment-grade tenants.
- **Credit Quality**: All troubled tenants current on rent. Stoughton property being aggressively marketed.
- **Interest Rate Strategy**: Higher-for-longer rates seen as buying opportunity. 6.5-7.5% cap rate targeting.


**【CEO Summary Section】**
- **Record 2024 Performance**: Achieved $164M in accretive acquisitions, including two mezzanine loans for healthcare developments in Lynchburg, VA. These loans offer mid-teens returns during construction with purchase options at completion.
- **Portfolio Resilience**: 99.9% net lease structure with 9.7-year weighted average lease term. Resolved all GenesisCare and Steward bankruptcies, retaining 100% of GenesisCare ABR through lease renewals and sales.
- **Balance Sheet Strength**: Upsized revolving credit facility to $600M (70% oversubscribed), with net debt-to-EBITDAre of 3.3x. Target long-term leverage of 4.5-5.5x.
- **Market Positioning**: Focus on Sunbelt healthcare facilities with investment-grade tenants. 66.9% of ABR backed by investment-grade tenants or guarantors.

**【CIO Portfolio Update】**
- **Lease Activity**: Renewed 1.1M sq. ft. (20% of portfolio) with 20-year extensions for Post Acute Medical. EBITDARM coverage improved to 5.3x (from 4.5x Q3), with <2% of ABR below 1x coverage.
- **Acquisition Pipeline**: $164M in 2024 purchases, including $85.8M Class A portfolio. Actively pursuing mezzanine loans and off-market deals in medical outpatient, rehab, and surgical facilities.
- **Risk Management**: Sold final GenesisCare asset for $1.7M and leased former Steward property to UC Regents. Actively marketing Stoughton, MA property for sale or lease.

**【CFO Financial Highlights】**
- **Earnings Growth**: GAAP net income $42.7M ($0.75/share) vs. $24M ($0.42/share) in 2023. AFFO $131.1M ($2.31/share) vs. $132.7M ($2.32/share).
- **Cash Flow**: Q4 cash NOI $41M (-4.3% vs. Q4 2023) due to asset sales and lease resets. Same-store NOI +1% year-over-year.
- **Capital Markets**: Hedged $250M term loan at 3.76% fixed rate. Increased liquidity with $600M revolving credit. Modified Dutch Auction repurchased 1.5M shares.
- **Dividend Policy**: Switched to quarterly dividends, first payment $0.40/share Q1 2025.

**【Q&A Key Takeaways】**
- **2025 Growth**: Target 7.5-15% portfolio expansion. $1.9B enterprise value. Focus on accretive acquisitions and mezzanine loans.
- **Credit Quality**: <2% of ABR below 1x EBITDARM. All troubled tenants current on rent. Stoughton property being marketed aggressively.
- **G&A Efficiency**: Run rate $22.5-23.5M/year. No C-suite additions planned. Scalable G&A for $3B+ portfolio.
- **Interest Rate Strategy**: Higher-for-longer rates viewed as opportunity to buy when others pause. 6.5-7.5% cap rate targeting.
- **Mezzanine Loan Timing**: Q1-Q2 2025 funding. Potential 2026 purchase options at accretive cap rates.


Actual	0.08	0.21	0.2	0.14	0.15	0.21	0.09
Forecast		0.14	0.23	0.22	0.22	0.19	0.17
Surprise	0.00%	+50.00%	-13.04%	-36.36%	-31.82%	+10.53%	-47.06%

Actual	43.55M	46.12M	46.55M	48.26M	48.54M	49.42M	50.08M
Forecast	--	45.89M	45.39M	46.10M	48.44M	49.05M	49.93M
Surprise	0.00%	+0.50%	+2.55%	+4.67%	+0.21%	+0.76%	+0.31%

SILA

SILA fundamentals

SILA Q4 2025 Earnings

Earnings Call

You can ask Aime

SILA

SILA fundamentals

SILA Q4 2025 Earnings

Earnings Call

SILA Earnings Call Summary for Q4/202511:00 AM on Feb 25, 2026

SILA Earnings Call Summary for Q3/202511:00 AM on Nov 5, 2025

SILA Earnings Call Summary for Q2/202511:00 AM on Aug 7, 2025

SILA Earnings Call Summary for Q1/202511:00 AM on May 8, 2025

SILA Earnings Call Summary for Q4/202411:00 AM on Feb 26, 2025

You can ask Aime